01 1Sandoz B2B
01 1PENICILLIN V POTASSIUM
01 1Switzerland
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-01-26
Pay. Date : 2018-01-05
DMF Number : 13295
Submission : 1998-09-01
Status : Active
Type : II
20
Sandoz Gmbh, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for A global leader in antibiotics.
One of their notable products is PENICILLIN V POTASSIUM, with a corresponding US DMF Number 13295.
Remarkably, this DMF maintains an Active status since its submission on September 01, 1998, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 26, 2018, and payment made on January 05, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
